Teva Pharmaceutical Industries
TEVA
A$26.18
Share price
-4.07%
Change (1 day)
-0.21%
Change (1 year)
Categories
Teva Pharmaceutical Industries (TEVA) Fails to deliver data
Key failure to deliver metrics for Teva Pharmaceutical Industries:
- Last SEC data release: 2025-05-14
- Last 15 days FTD volume: A$0.36 M
- Last 3 months FTD volume: A$11.71 M
- Last year FTD volume: A$11.71 M
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for Teva Pharmaceutical Industries (TEVA) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for Teva Pharmaceutical Industries (TEVA) - since 2013
Volume in USD (price x number of shares), data since 2013Teva Pharmaceutical Industries (TEVA) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2025 | A$17.29 M | -52.92% |
| 2024 | A$36.72 M | -6.93% |
| 2023 | A$39.45 M | -1.93% |
| 2022 | A$40.23 M | 32.42% |
| 2021 | A$30.38 M | -16.46% |
| 2020 | A$36.36 M | -69.06% |
| 2019 | A$0.11 B | -54.74% |
| 2018 | A$0.25 B | 30.92% |
| 2017 | A$0.19 B | 202.61% |
| 2016 | A$65.56 M | -79.41% |
| 2015 | A$0.31 B | 23.96% |
| 2014 | A$0.25 B | 830.48% |
| 2013 | A$27.6 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3 months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Novartis NVS | A$50.39 M | A$0.16 B | 🇨🇭 Switzerland |
 Sanofi SNY | A$24.53 M | A$42.3 M | 🇫🇷 France |
 GlaxoSmithKline GSK | A$0.16 B | A$0.31 B | 🇬🇧 UK |
 Pfizer PFE | A$35.84 M | A$0.35 B | 🇺🇸 USA |
 Merck MRK | A$45.1 M | A$0.17 B | 🇺🇸 USA |
 Dr. Reddy's Laboratories RDY | A$14.21 M | A$19.6 M | 🇮🇳 India |
 AstraZeneca AZN | A$38.37 M | A$0.14 B | 🇬🇧 UK |